Pedram Razavi, MD, PhD

About Me

I am a board-certified medical oncologist and physician-scientist focused on personalized care for people with breast cancer. I work closely with an exceptional team of surgeons, radiation oncologists, and nurses to provide the best care to my patients and their families.

My research focuses on cancer genomics to understand the reasons behind the resistance or response to therapy and ultimately to develop molecular biomarkers to guide precision medicine. I am developing liquid biopsy assays (circulating tumor DNA assays) to precisely detect tumor genomic changes in blood samples. This information may help us monitor the extent of the disease and its heterogeneity, predict a person’s response to treatment, and detect early-stage and minimal residual disease. My ultimate goal is to use the insights gained from these studies to develop new treatment strategies for people with breast cancer.

  • Clinical Expertise: Breast Cancer
  • Awards and Honors: Breast Cancer Alliance Young Investigator Award
  • Languages Spoken: English; Farsi
  • Education: MD, Tehran University of Medical Sciences; MPH, University of Southern California; PhD, University of Southern California
  • Residencies: Internal Medicine - University of Southern California
  • Fellowships: Medical Oncology - Memorial Sloan Kettering Cancer Center
  • Board Certifications: Medical Oncology; Internal Medicine

My Research

Microscope iconAn icon showing a microscope. View my lab Arrow rightAn icon showing an arrow pointing to the right.

See Pedram Razavi’s laboratory
research at Memorial Sloan Kettering.

See My Colleagues


Visit PubMed for a full listing of Pedram Razavi’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.